Enabling Technologies
Print
Keyword
    advanced

3D Cell Culture developments to improve in vitro analyses. Spring 11

By Prof Stefan Przyborski
Improved in vitro models are required to aid the identification and assessment of candidate molecules for pharmaceutical development. Conventional cell culture models involve the growth o...
Read more...

Bulk Reagent Dispensers: ubiquitous liquid handling tool for microplate filling! Fall 10

By Dr John Comley
The initial success of the bulk reagent dispenser (BRD) as an automated liquidhandling product can be attributed to its simplicity and low cost. Its current role as an essential dispensin...
Read more...

Mass Spectrometry in Drug Discovery and Development. Fall 10

By Dr Stephen Naylor and Paul T. Babcock
Mass Spectrometry is a mature technology predicated on a premise demonstrated almost a century ago. It is widely used in most scientific disciplines involving basic research or industrial...
Read more...

High throughput flow cytometry for discovery at UNMCMD and the NIH Molecular Libraries Initiative. Fall 10

By Dr Larry A. Sklar and Dr Bruce S. Edwards
Commercial flow cytometers became widely established in research and clinical laboratories in the 1980s. Once the domain of immunologists and hematologists for cell sorting and analysis, ...
Read more...

REAL-TIME PCR - where we are and where are we heading. Spring 10

By Dr Mikael Kubista
Quantitative real-time PCR is becoming mature technology for the quantification of nucleic acids. It is spreading wide outside its original use in the research laboratories, becoming pref...
Read more...

Compound Profiling: size impact on primary screening libraries. Spring 10

By William Downey, Cindy Liu and Dr Jennifer Hartigan
A recent report examines the trends in utilisation of compound libraries, as well as the impact of profiling on the size of screening decks. The drivers for choosing between large or focu...
Read more...

Automation Of Solid/Powder Dispensing: much needed, but cautiously used! Summer 09

By Dr John Comley
This article investigates solid/powder dispensing in pharma and biotech, examines where it is most used, whether there exists a need to apply automation and what is motivating its wider u...
Read more...

Restructuring proteomics to enable personalised cancer care. Summer 09

By Dr Henry Rodriguez
The genomics community has made great strides in our understanding of the molecular basis of cancer and these advances are slowly beginning to change the way we diagnose and treat patient...
Read more...

Bringing cost and process efficiency to next generation sequencing. Summer 09

By Dr Fred P. Ernani, and Dr Emily M. LeProust While next-generation sequencing has revolutionised the way genomes are sequenced, this technology possesses a fundamental weakness – the inability to easily target specific regions of ... Read more...

Letting the Target Determine your Compound Acquisition Strategy. Spring 09

By Dr John Harris With compound libraries likely to remain the cornerstone of hit and lead discovery for the foreseeable future, this paper seeks to summarise current and future approaches to optimal libra... Read more...

Livening up HCS Imaging. Spring 09

By Dr John Comley With the aid of recent end-user feedback, this article investigates interest in and use of live cell and kinetic HCS imaging; most wanted application areas: advantages of live cell HCS im... Read more...

The protein biochip content problem. Summer 03

By Dr Steven Bodovitz The protein biochip industry has a content problem that is not only slowing its development as a whole but possibly the development of the entire proteomics industry. Read more...

The Microplate Market Past, Present and Future. Spring 09

By Dr Peter Banks Microplates and the peripheral markets of liquid handling and detection technologies exist within almost all laboratories performing assays. This article discusses what, if any, are their... Read more...

Generation II DNA Sequencing Technologies. Spring 09

By Dr Stephen F. Kingsmore, Dr Jenny C. van Velkinburgh, Dr Joann Mudge, and Dr Gregory D. May Generation II DNA sequencing has been widely heralded as a disruptive technology, generating tens of millions of random short sequences at efficiencies up to 20,000-fold greater than Gene... Read more...